Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
1997-10-21
pubmed:abstractText
The MHC class I molecules present antigenic peptides to CTL. The peptides are delivered to the secretory pathway by TAP, which is formed by the association of MHC-encoded TAP1 and TAP2 gene products. Tumor cells incubated or transfected with IL-10 had decreased but peptide-inducible expression of MHC class I, decreased sensitivity to MHC class I-restricted CTL, and increased NK sensitivity. We here demonstrate that IL-10 expression in the murine lymphoma RMA inhibits the TAP-dependent translocation of peptides to the endoplasmic reticulum, resulting in accumulation of immature MHC class I molecules in the endoplasmic reticulum and subsequently low expression of cell surface MHC class I molecules. This finding is explained by a down-regulation of expression of TAP1 and TAP2, observed in IL-10-transfected RMA cells as well as in IL-10-transfected P815 mastocytoma cells. In the J558L plasmacytoma cell line, constitutively expressing high levels of IL-10, increased TAP-dependent translocation of peptides and expression of cell surface MHC class I could be induced by IL-10 antisense expression. IL-10 is the first example to demonstrate that a cytokine can decrease the expression and function of the TAP1/2 molecular complex and, in more general terms, the first example of a cytokine with an inhibitory effect on MHC class I-mediated Ag presentation.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0022-1767
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
159
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3195-202
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:9317117-ATP-Binding Cassette Transporters, pubmed-meshheading:9317117-Animals, pubmed-meshheading:9317117-Antigen Presentation, pubmed-meshheading:9317117-Biological Transport, pubmed-meshheading:9317117-Down-Regulation, pubmed-meshheading:9317117-Endoplasmic Reticulum, pubmed-meshheading:9317117-H-2 Antigens, pubmed-meshheading:9317117-Immunity, Innate, pubmed-meshheading:9317117-Interleukin-10, pubmed-meshheading:9317117-Killer Cells, Natural, pubmed-meshheading:9317117-Lymphoma, pubmed-meshheading:9317117-Mast-Cell Sarcoma, pubmed-meshheading:9317117-Mice, pubmed-meshheading:9317117-Mice, Inbred C57BL, pubmed-meshheading:9317117-Peptides, pubmed-meshheading:9317117-Plasmacytoma, pubmed-meshheading:9317117-Protein Processing, Post-Translational, pubmed-meshheading:9317117-T-Lymphocytes, Cytotoxic, pubmed-meshheading:9317117-Transfection, pubmed-meshheading:9317117-Tumor Cells, Cultured
pubmed:year
1997
pubmed:articleTitle
Down-regulation of the expression and function of the transporter associated with antigen processing in murine tumor cell lines expressing IL-10.
pubmed:affiliation
Microbiology and Tumor Biology Center, Karolinska Institutet, Stockholm, Sweden. flavio.salazar@mtc.ki.se
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't